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1. Introduction
For many years the adult bone marrow (BM) was described as a highly vascularised organ
consisting histologically of a network of reticular cells, some of them intimately associated
with blood vessel walls, so-called adventitial reticular cells, in whose holes mature and
developing hematopoietic cells can be found. In long bones, central longitudinal arteries give
rise to radial arteries that branch into arterioles near the endosteum where they connect to
venous sinusoids that extend back toward the central region where they unite to form a large
central sinus. The sinusoidal network occupies 30 ± 5 % of BM volume whereas arterioles
comprise a smaller volume, 1.2 ± 0.1 % of total BM [1]. Macrophages, adipocytes, endosteal
bone-lining cells and nerve endings also form part of the haematopoietic microenvironment
of BM.
Twenty years ago, it was proposed that hematopoietic stem cells (HSCs) and their progeny
occupied specific places (niches) in the BM network, a topological arrangement necessary to
create a gradient of maturation from the bone endosteum, in which primitive B progenitor
cells were identified, to central blood vessels through which mature B lymphocytes migrated
into the blood circulation [2]. Thus, the relevance of bone lining cell (endosteal cells)-HSC
interface was emphasized for the control of haematopoiesis. However, more recently based
on the phenotypic definition of HSCs as CD150+CD48-CD41-Lin-cells, most early hemato‐
poietic progenitors appear to really be in contact with sinusoidal endothelia, defining the so-
called vascular niche [3]. Despite this evidence, the cells that organize these different BM
microenvironments, the physiological relationships between them and molecules governing
their functioning remain elusive. In the present chapter, we will be trying to clarify these issues
© 2014 The Author(s). Licensee InTech. This chapter is distributed under the terms of the Creative Commons
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providing current evidence on the functional niches operating in the adult bone marrow, their
main cell components and the mechanisms governing their homeostasis. Niches involved in
the homing and maintenance of distinct lymphoid cell subsets will be also addressed as well
as the available information on the organization of hematopoietic niches occurring in primitive
vertebrates that lack a functional bone marrow.
2. The existence of an endosteal niche in the adult BM is controversial
Bone development and the appearance of hematopoietic niches occur concomitantly during
development. In foetal mice, the vascular invasion of specific chondrogenic sites favours bone
formation, organizes the BM and seeds it with HSCs. Prior to the appearance of a bone
microenvironment, HSCs occurring in foetal liver cannot home into the BM. In addition,
injected HSCs disappear from the blood circulation to home rapidly in the endosteal niche [4].
On the other hand, E14.5 bone tissue grafted under the kidney capsule of syngeneic mice
produces bone containing bone marrow that houses HSCs, and grafted CD105+Thy-1-cells
isolated from E14.5 bone recruit blood vessels, produce ectopic bone through endochondral
ossification and generate a BM capable of recruiting long term (LT) HSCs. In any experimental
condition, the presence of bone was mandatory for BM organization [5]. Mixed multicellular
spheroids containing CD45-CD105+CD31-Ter119-Sca-1+CD51+osteoprogenitors form a 3D
hematopoietic niche that produces CXCL12 and osteopontin, retaining HSCs [6]. Nevertheless,
bone marrowless vertebrates contain numerous hematopoietic loci in which HSCs develop in
the absence of bone. Remarkably, the stroma of these organs morphologically resembles that
of mammalian BM [7].
The existence of an endosteal niche gained considerable support several years ago when it was
shown that endosteal cells produced several molecules involved in HSC maintenance,
including G-CSF [8], thrombopoietin, angiopoietin [9, 10], CXCL12 [11], Jagged 1, Wnt ligands,
among others [12, 13]. They, also, expressed adhesion molecules (VCAM, ICAM-1; N-cadherin,
CD44, CD164) that could mediate endosteum-HSC interactions [4]. HSCs express Ca++-sensing
receptors that recognize Ca++concentration in endosteum. In mice defective in these receptors
HSC migrate into the BM in response to CXCL12 but do not anchor to the endosteum [4]. On
the other hand, an increase in osteoblasts or osteolinage cells through enforced expression of
parathyroid hormone receptor 1 [14] or by conditional inactivation of BMP receptor I [15]
resulted in increased numbers of HSCs. Conversely, conditional depletion of osteolinage cells
is concomitant with a loss of HSCs in the BM and extramedullary haematopoiesis [16].
However, recently some of these results have been questioned. Mice deficient in biglycan, a
leucine-rich repeat proteoglycan of the connective tissue, have reduced osteoblasts but contain
normal numbers of HSCs [17]. Osteoblast depletion in transgenic mice expressing thymidine
kinase under the collagen α1 promotor courses with important alterations in haematopoiesis
but only slight changes in the Lin-Sca-1+c-Kit+fraction of hematopoietic progenitors [16]. On
the other hand, increased numbers of short term HSCs after parathyroid treatment could be
mediated through Wnt ligand production by T cells [18] rather than through osteoblast
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expansion. Moreover, an increase in osteoblasts is not sufficient to increase HSCs. Thus, the
treatment of mice with strontium, a bone anabolic agent, induces expansion of mature
osteoblasts but does not affect the number or function of HSCs [19]. Likewise, in mice suffering
chronic arthritis that produces osteoblast suppression, HSCs exhibit a normal behaviour [20]
and conditional deletion of CXCL12 [21, 22] or SCF [23] from mature osteoblasts has no effect
on HSCs, while osteoblasts would promote proliferation and differentiation of lymphoid
progenitors [21].
A good example of the controversy about the significance of endosteal niche for haematopoi‐
esis is the role played by the N-cadherin positive cells. As mentioned above, N-cadherin was
pointed out to be an important adhesion molecule for endosteal cell-HSC interactions. These
interactions were considered to be occurring between osteoblasts and HSCs, but other studies
indicated that N-cadherin was largely expressed on immature osteolinage cells called spindle-
shaped N-cadherin+osteoblasts [15]. These cells also express high levels of SCF and CXCL12
and support long term repopulating activity of HSCs [24]. In this respect, N-cadherin knock‐
down or expression of a dominant negative molecule in HSCs inhibited their repopulating
capacity [25, 26] but conditional deletion of N-cadherin encoding gene in HSC had no effects
on HSC number, mobilization, proliferation or repopulating capacity [25, 27].
In fact, a key issue to understanding these controversial results is the different cell composition
attributed to the endosteum in various studies: whereas the earliest studies assigned any effect
of endosteal niches to osteoblasts, more recent studies consider that, apart from osteoblasts,
osteoclasts, osteoprogenitor cells, blood vessels and reticular cells provide a more accurate
idea of the endosteal cell components and their function in the BM microenvironment. It has
been proposed that osteoprogenitors rather than osteoblasts provide a functional niche for
HSCs [28], whereas osteoclasts contribute to endosteal niches governing osteoblast maturation
[29]. In this respect, macrophages interspersed between endosteal osteoblasts, called osteo‐
macrophages, support osteoblast function because their depletion in vivo leads to osteoblast
disappearance and HSP mobilization [30], and RANK (receptor activator of nuclear factor κ
B) ligand, essential for osteoclast maturation, induces mobilization of hematopoietic progen‐
itors to the circulation [31]. In fact, osteoprogenitors, osteoblasts and osteoclasts are in a
dynamic balance on the endosteal surface. Furthermore, recent evidence also supports a role
for osteocytes in the function of the endosteal niche [32]. An analysis of the kinetics of gene
expression in mice treated subcutaneously with injections of G-CSF each 12 hours showed that
osteocytes responded more rapidly than osteoblasts to G-CSF. Thus, from the 4th dose onwards
a rapid suppression of specific osteocyte genes was observed from the 1st or 2nd dose before
HSC mobilization. After 8 doses of G-CSF, osteocytes showed fewer cell processes that
connected them with endosteal osteoblasts. Remarkably, the specific elimination of osteocytes
that disrupted the bone cell network, resulted in severe impairment of G-CSF-mediated HSC
mobilization, as previously observed in other experimental models [33-35]. The authors
suggest that these defects in HSC mobilization are due to impairment of the endosteal niche
via altered communication between osteocytes and osteoblasts. Thus, changes in osteoblasts
would be secondary to osteocyte depletion.
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Nevertheless, results that emphasize a close association between HSCs and vascular endothe‐
lia, and those emphasizing the relevance of endosteal niche are not discordant because both
HSCs and early committed pluripotent progenitors are perivascular but preferentially occupy
the highly vascular endosteum [1]. However, it is more difficult to demonstrate that endosteal
and vascular niches represent functionally different environments housing quiescent HSC and
cycling hematopoietic progenitors, respectively, as suggested by some authors [12, 36]. The
endosteal niche would house dormant, primitive HSCs due to its presumptive hypoxic
condition [37, 38].It has been reported that disruption of HIF 1α (hypoxia-inducible factor)
coursed with loss of HSC quiescence and repopulating activity whereas stabilization of
HIF-1α induced opposite effects [39, 40], but CFU-S associated with endosteum has been
described as non-quiescent cells and, indeed, endosteum is a highly vascularised and,
therefore, presumably well-oxygenated area of the BM. Thus, it has been proposed that
hematopoietic progenitors exhibit an intrinsic hypoxic profile independently of their location
in the BM [41, 42]. On the other hand, cycling hematopoietic progenitors present in the vascular
niches would be ready to respond to the physiological demand of blood cells. However, a
recent study which combines three-dimensional BM imaging with computational modelling
to carefully analyze relationships between HSCs and BM stromal component, including blood
vessels, shows that different vascular niches house quiescent or proliferating stem cells.
Whereas arterioles that occur predominantly close to bone [1], contribute to a niche that
maintains quiescent HSCs, sinusoids could represent a niche which houses proliferating HSCs
[43]. In addition, E-selectin expressed in certain BM sinusoids [44] promotes HSC proliferation
and its blockade protects HSCs following chemotherapy or γ-irradiation [45].
3. The existence of a vascular niche
As described above, a restricted analysis of the topological position of HSC identified by the
expression of SLAM family molecules CD150, CD244, CD48 and CD41 [46], together with
experiments that indicate the relevance of vascular meshwork for the biology of hematopoietic
progenitors led to a hypothesis of the occurrence of a so-called vascular niche [36]. Thus,
vascular endothelial cells promote haematological recovery in mice following total body
irradiation [47] inducing HSCs to enter in cycle after stimulation with different injury factors
[48] and conditional deletion of VEGFR2, which inhibits the regeneration of sinusoidal
endothelia, impedes the hematopoietic recovery following sublethal irradiation [47]. Also,
specific activation of BMPR1A in endothelial cells increases the number of HSCs and hema‐
topoietic recovery after myeloablation [49]. HSC mobilization induced by different agents
(cyclophosphamide, G-CSF) that results in extramedullar haematopoiesis is associated with
splenic sinusoids [36] and thrombocytopenic mice only recover thrombopoiesis in the presence
of BM endothelial cells [50].
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4. The cellular components of distinct BM microenvironments
For many years, the characterization of BM stromal cells was merely morphologic identifying
a supporting network consisting largely of reticular cells, adventitial reticular cells and blood
vessels whose functions were unknown. An important part of our knowledge of the presump‐
tive functions of these BM stromal cells comes from studies in which genes important for HSC
maintenance (i.e., CXCL12, SCF, TGFβ) are selectively deleted from different niche cell types
[42, 51]. Unfortunately, results arising from these studies are controversial partially due to the
disparity of these experimental models from physiological conditions and different degrees
of specific deletion of the genes studied.
CXCL12, a chemokine implicated in the retention of CXCR4 (the CXCL12 receptor) positive
hematopoietic multipotent progenitors is produced by different cell types of BM stroma,
including bone-lining cells, but particularly by reticular cells that were named CAR cells
(CXCL12 abundant reticular cells) [36]. A strong CXCL12 expression was demonstrated in a
small VCAM+reticular cell population scattered throughout the BM. It constitutes a relatively
homogeneous CD45-CD31-Sca-1-PDGFRβ+cell population that in human BM could corre‐
spond to CD146-expressing subendothelial cells [31]. Selective depletion of CAR cells results
in a drastic reduction of hematopoietic progenitors as well as of both cycling B lymphocytes
and erythroid progenitors. On the other hand, CAR cells express adipogenic and osteogenic
genes and are capable of differentiating in vitro to adipocytes and bone lineage cells.
On the other hand, nestin, a neuroectoderm stem cell marker, has been used to identify another
stromal cell type in murine BM [52]. Nestin+cells have also been reported in human foetal and
adult BM [53]. Previously, other authors identified self-renewing osteoprogenitors from
stromal cultures containing all the human BM CFU-F activity, although their phenotype
(CD45-CD146-or CD45-CD271+CD146-/lo) is a matter of discussion [54, 55]. PDGFRα
+CD51+stromal cells isolated from human BM form self-renewing clonal mesenpheres and
support maintenance and expansion of human hematopoietic progenitors in a dose-dependent
manner [56]. Remarkably, these authors indicate that these PDGFRα+CD51+stromal cells
comprise a subset of CD146+cells associated with hematopoietic and MSC activities in foetal
human BM. Nestin-positive cells are morphologically similar to pericytes; in fact, they appear
to be largely restricted to the perivascular areas in intimate association with HSCs and to
heavily express genes known to be involved in HSC maintenance, such as CXCL12, SCF,
angiopoietin 1, IL7, V-CAM and osteopontin. Nestin+cells are innervated by the sympathetic
nervous system, express β3-adrenergic receptors, mediate G-CSF-induced HSC mobilization
and regenerate in vivo a BM stroma capable of supporting haematopoiesis. Furthermore, β3-
adrenergic stimulation reduces the expression of the above-mentioned genes involved in HSC
biology [52]. Depletion of nestin+cells reduces by half the HSC numbers in BM increasing
concomitantly in the spleen. Relationships between nestin+cells and CAR cells are unclear.
They could represent two overlapping BM stromal cells, nestin+cells being more primitive
because they are less abundant, contain all CFU-F activity of bone marrow, exhibit autorenewal
capacity and are able to differentiate into osteoblasts, chondrocytes and adipocytes.
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On the other hand, it has been proposed that the BM stromal network, largely formed by CAR
cells and nestin-expressing cells, would constitute a functional syncytium through gap
junctions capable of affecting the behaviour of hematopoietic progenitors modulating CXCL12
secretion [57]. Nestin+MSCs heavily express connexin (Cx) 43 and Cx45, and G-CSF mediated
reduction of CXCL12 expression is intimately related to decreased expression of both Cx43
and Cx45. On the contrary, the pharmacological blockade of gap junctions reduces the CXCL12
expression preventing homing into BM of mononuclear cells. In addition, a tight correlation
occurs in confluent cultures of human BM-MSCs between the functional modulation of gap
junctions and CXCL12 production. Gap junctions could modulate CXCL12 mediating gene
transcription or directly acting on CXCL12 secretion. Loss of function of the Cx45 gene courses
with reduced CXCL12 transcription particularly if Cx 43 transcription is also disrupted. On
the other hand, Ca++release, due to osteoclast activity in bone, necessary for AMPc-dependent
PKA activation involved in CXCL12 secretion, is transmitted by gap junctions [58]. However,
other studies have proven that Cx43 deficiency increases CXCL12 secretion, although it
compromises HSC homing and hematopoietic recovery following myeloablation [59].
Cre-recombinase expressed under the control of leptin receptor (LepR) regulatory elements in
the mouse BM [23] identified another perivascular stromal cell subset that, like the CAR cells
and nestin+cells, expresses high levels of CXCL12 and SCF (c-Kit ligand).
A fourth element, in this case related to BM innervation, completes, for the moment, the myriad
of stromal cells identified in the mouse BM. GFAP+integrin β8+(a Schwann cell marker), non-
myelinated Schwann cells have been identified surrounding sympathetic nerves in BM. They
produce important factors for HSC maintenance and appear to be in close contact with high
numbers of hematopoietic progenitors [60]. Presumably, BM GFAP+cells are the main cell type
processing latent TGFβ into an active form of the molecule, key for controlling the HSC niche.
In fact, surgical sympathectomy performed by ligation of the sympathetic trunk reduces the
HSC frequency and provokes HSC differentiation [33].
On the other hand, at least a subset of the total nestin-expressing cells present in the BM stroma
could correspond to adventitial reticular cells identified in the EM studies and in vivo
equivalents of the so-called mesenchymal stem cells (MSCs), an in vitro characterized BM
stromal cell subset that exhibits interesting immunomodulatory properties and is extensively
used in cell therapy [61]. Currently, it is assumed that MSCs represent approximately 0.001%
to 0.01% of the BM nucleated cells, 10 fold less than the percentage of HSCs [62]. In 2007, [54]
and later other authors [63-65] pointed out that MSC could be identical to, or derived from,
pericytes, as previously indicated for nestin+cells. In addition, the CD146+subendothelial cell
population of BM stroma, after ex vivo culture, produces bone, adipocytes and a stroma
capable of supporting haematopoiesis. Other authors have identified a non-hematopoietic
perivascular cell population that expresses both PDGFRα and Sca-1 and, after intravenous
injection, produces perivascular cells, but also osteoblasts and adipocytes [66]. In human BM,
Stro-1+stromal cells support haematopoiesis, exhibit capacity to differentiate into multiple
mesenchymal lineages [67, 68] and after long-term culture express αsM-actin, as vascular
smooth muscle cells. In vivo, asM-actin+cells occur in both foetal and adult bone marrow and
exhibit long cell processes in intimate contact with HSCs [69], similarly to the alkaline
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phosphatase adventitial reticular (AdR) cells described previously [70]. The AdR cells express
CD271 and appear in the foetal BM before the presence of HSCs [71]. CD146+cells, another
BM-MSC subset [55], are also morphologically and physiologically similar to AdR cells and,
after ex vivo expansion, express alkaline phosphatase, α-SM actin and CXCL12 [54].
Although results need further confirmation, [43] two types of nestin+cells have recently been
reported in the murine BM. Nestinhi expressing cells appeared along arterioles in both
cancellous and long bone BM, closely associated with tyroxine hydroxylase-positive sympa‐
thetic nerves and GFAP+Schwann cells. Nestinweak cells were reticular in shape and appeared
associated to blood sinusoids. Transcriptome analysis also revealed differences between the
two nestin+cell types: periarteriolar nestinhi cells expressed mainly genes related with HSC
biology whereas reticular nestinweak cells were particularly enriched in genes involved in DNA
replication and cell cycle.
On the other hand, clonal analysis revealed that BM nestin+cells represent a mixed population
composed of neural crest (NC) stem cells plus a few MSCs [72]. Classically nestin+MSC of adult
BM were considered to be mesodermal in origin [73], but recent studies have conclusively
demonstrated that some adult BM-MSCs derive from the NC [74-78]. The vertebrate NC cells
are a multipotent population that gives rise to multiple types of derivatives [79]. In chick
embryos, a common mesenchyme-neural progenitor derived from the neural crest has been
described [80] and tracing studies using the Sox1 neuroepithelial marker and PO (protein O)
NC marker indicate that the first wave of trunk MSC come from the neuroepithelium rather
than from the mesoderm, although MSC derived from Sox1+PO+cells decrease gradually and
appear to be substituted by MSCs from other unknown sources [74]. Murine NC stem cells
migrate in the blood to the BM via the AGM region between E12.5 and E15.5 similar to HSCs
and form spheres that express nestin as BM-MSCs [75]. It has been pointed out that TGF-β
signalling confers mesenchymal potential to NC cells and suppresses their neurogenic
potential [81] supporting the hypothesis that GFAP+Schwann cells intimately associated with
nestin+cells in the murine BM produce TGF-β that could affect the BM-MSC properties. On
the other hand, the neuroectodermal origin of some BM-MSC could confer them a neural
potentiality useful for Cell Therapy. In this respect, cranial NC cell-derived MSCs from
gingivae show a high capacity to differentiate into neural cells [82] and BM stem cells have
been described to differentiate into both neurons and glial cells in vivo and in vitro [83, 84].
However, other studies demonstrate that NC derived BM-MSCs are not more competent than
mere MSCs or whole bone MSCs at differentiating into neurons and in vivo recovery of the
experimentally-damaged dopaminergic system [85].
As mentioned above, it is difficult to establish clear relationships between all these cell types
of BM stroma. It has been proposed that they are overlapping cell subsets because LepR is
among the top 1% most highly expressed genes in sorted nestin+cells [52] and also in CAR
cells [22]. However, conditioned deletion of SCF gene in either osteoblasts, nestin+cells,
endothelial cells or perivascular LepR+cells only negatively affects the HSC frequency in the
two last experimental conditions suggesting that LepR+cells and nestin+cells are different
components of BM stroma [23]. [51] have recently proposed that CAR+cells, which represent
the highest BM stromal cell subset (0.26% of total BM nucleated cells), would encompass nestin
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+cells (0.08%), GFAP+cells (0.004%) and LepR+cells (0.012%) whereas the nestin+cell subpo‐
pulation would partially include LepR+cells. On the contrary, [86] found only a partial
overlapping of nestin+MSCs with the other three stromal cell types. In fact, all GFAP+cells
express nestin but not PDGFRα, although nestin+cells and PDGFRα cells largely overlap. Thus,
BM GFAP+cells seem to differ from PDGFRα MSCs, as further supported by the finding that
they do not express smooth muscle actin [60]. Recently, [43] reported that LepR+cells and
reticular nestinweak cells largely overlap but they did not find overlapping between LepR+cells
and periarteriolar nestinhi cells that these authors consider to be related to pericytes that express
Ng2 and α-smooth muscle actin.
Some evidence supports reciprocal interactions between HSCs and the niche. After acute
bleeding, HSCs secrete BMP2 and BMP6 that differentiate MSCs to osteoblasts [87]. Also,
megakaryocytes located close to the endosteum stimulate osteoblasts by secreting BMP2, 4
and 6 [50, 88].
5. Rhythms and haematopoiesis
HSCs, like other stem cells, are affected by systemic signals, including those associated with
nutrition, seasonal and circadian rhythms, exercise, mating, pregnancy, etc. [89]. Recently, [90]
have reported that HSCs suffer sexual dimorphism due to estrogens that directly affect HSC
biology. More interestingly within the context of this chapter are results that suggest that
certain physiological biorhythms known to occur in the BM could be mediated through its
stromal components. The close association between nerve endings, GFAP+Schwann cells and
some nestin+cells (ultrastructurally identified as adventitial reticular cells [91]), as well as the
above mentioned possible neuroectodermic origin of part of this BM cell population suggested
by some authors support this hypothesis.
A central clock in the central nervous system [92] orchestrates a uniform temporal programme
by synchronizing multiple peripheral clocks that occur in practically all cell types [93]. The
haematopoietic system exhibits circadian rhythms that oscillate according to the rest-activity
phase that, by turn, depend on whether the species is diurnal or nocturnal. Thus, the numbers
of HSCs, committed progenitor cells and most mature leukocytes, except CD8+T lymphocytes
[94] peak in the circulation during the resting phase (night for humans and day for rodents)
and decrease during the active period [95, 96].
Haematopoietic progenitors and mature immune cells leave the BM to enter the blood
circulation at the beginning of the resting phase [97], migrating to tissues predominantly
during the active phase [98]. The mobilization from BM is dependent on local sympathetic
innervation which down-regulates the CXCL12 expression in the BM in close association with
a reduced CXCR4 expression of haematopoietic progenitors [99] and both CD4+and CD8+T
cell subsets [94]. On the contrary, the onset of the active phase is related to a peak of gluco‐
corticoids, adrenaline, noradrenaline, TNF and IL1β [95, 96].
Numerous data support a role for the sympathetic nervous system (SNS) in regulating HSC
trafficking. Noradrenalin administration stimulates proliferation and migration of human
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HSCs [100], and Cgt-/-mice, deficient in the UDP-galactose ceramide galactosyl transferase
necessary for sulfatide synthesis, a key component of myelin, have compromised G-CSF-
mediated HSC mobilization [33]. Nevertheless, the most remarkable information comes from
studies using G-CSF, a cytokine that mobilizes HSCs from the bone marrow to peripheral blood
by stimulating adrenergic receptors on target cells resulting in decreased secretion of CXCL12
[33]. The first studies identified osteoblasts as the target stromal cell for the effects observed
on HSCs because β2 adrenergic receptor activation on osteoblasts increases the expression of
the vitamin D receptor necessary for G-CSF induced HSC mobilization [34, 101]. Recently, it
has been proposed that osteocytes, which indirectly affect osteoblasts on the endosteal surface,
could also mediate G-CSF dependent HSC mobilization through a sympathetic tone [32]. This
possibility was discarded because adrenergic receptors involved in these processes were
largely β3 receptors not expressed on osteoblasts but on CAR cells and nestin-expressing
perivascular cells [33, 52]. Presumably, both adrenergic receptors contribute to regulate
haematopoiesis in BM [102].
The circadian rhythms could therefore be explained as a consequence of transmitted informa‐
tion from the central pacemaker to the BM through SNS that rhythmically secretes noradre‐
nalin activating β receptors expressed on different stromal cells. Neural signals could be
propagated through the BM stroma via gap junctions whose effects on HSC mobilization have
already been commented. Chemical sympathectomy, by using 6-OH dopamine, abolishes the
rhythms of circulating blood cell precursors and surgical denervation of mouse tibiae courses
with the disappearance of rhythmic CXCL12 oscillations in the denervated limbs [86].
However, recent results suggest that the process could be more complex and the effects of
innervation would vary rhythmically and affect different processes in the BM. Systemic
activation of β adrenergic receptors does not increase circulating haematopoietic progenitors
unless HSC homing is also blocked [97] suggesting that adrenergic stimulation might not only
affect mobilization but also homing of haematopoietic progenitors in the BM and/or peripheral
tissues [102]. Indeed, when mice defective in E-and P-selectins showing additional α4 integrin
blockade, which inhibited the homing to BM, received isoproterenol, an adrenergic antagonist,
during the morning phase they showed considerable HSC mobilization. On the contrary, if
isoproterenol administration occurred 1 hour earlier than the onset of light the HSC mobili‐
zation was prevented [86].
In any case, it is not easy to establish a direct relationship between sympathetic innervation
and mobilizing agents (i.e., G-CSF) that induce haematopoietic progenitor egress from the BM,
although some evidence for this is available. Administration of either G-CSF or β3 adrenergic
agonists has similar effects on the haematopoietic niche and HSC mobilization [52]. Tyrosine
hydroxylase neurons from the murine superior cervical sympathetic ganglion express G-CSF
receptors and this cytokine promotes neuron survival after brain damage [103]. On this basis,
[104] have shown that G-CSF increases the sympathetic tone modifying the capacity of neurons
to uptake noradrenalin and, consequently, increasing available catecholamine for BM target
cells. Furthermore, in vivo administration of G-CSF plus noradrenalin re-uptake inhibitors,
such as desipramine or reboxetine, induce significantly higher numbers of haematopoietic
progenitors in the blood circulation, without changes in BM cell content, than those of animals
The Adult Hematopoietic Niches — Cellular Composition, Histological Organization and Physiological Regulation
http://dx.doi.org/10.5772/58634
29
receiving only cytokine. These studies support a direct effect of G-CSF on the sympathetic
terminals through signalling transmitted by specific receptors on neurons and noradrenalin
uptake inhibition.
6. The role of myeloid cells in the hematopoietic niche
We have extensively reported the organization of the main components of BM stroma and
their relevance for regulating haematopoiesis. However, many other cells present in the BM
that do not form part of the stromal reticular network are also important for this regulation.
A clear example is the response of BM to G-CSF administration that is known to have provided
such important information on the functioning of the haematopoietic niche. It is obvious that,
apart from the BM stromal cells, monocytes/macrophages (Mo/MØ) and granulocytes are the
main targets of its action. On the other hand, numerous inflammatory molecules produced
mainly by leukocytes affect the behaviour of HSCs in both cell autonomous and non-cell
autonomous fashion [105]. Could the response to C-CSF administration between stromal cells
and leukocytes be coordinated? or, by contrast, does G-CSF administration induce specific,
independent effects on each BM cell type that expresses receptors for this growth factor?
Moreover, if this presumptive cooperation exists, how is it established?
Various results support the involvement of monocytes (Mo) and macrophages (MØ) in the
functional regulation of the HSC niche [106]. In mice, the loss of MØ results in decreased self-
renewal capacity and retention of HSC [107, 108], and it has been reported that G-CSF
signalling in a Mo cell line is sufficient to induce HSC mobilization [109]. Is it possible to
reconcile these results in which G-CSF mediated HSC mobilization depend on Mo/MØ with
those previously described in which HSC egress seems to be mediated by changes in sympa‐
thetic tone that affects CXCL12 secretion by CAR cells and/or nestin+cells ? Some results try
to do this although stromal cell types affected by Mo/MØ activity are controversial. MØ
elimination by in vivo administration of clodronate-loaded liposomes or use of Fas-induced
apoptosis transgenic mice courses with loss of endosteal osteoblasts and reduced HSC
mobilization into the blood [108]. In these experiments, endosteal osteomacrophages were
particularly affected. In this same study [107] and others, it has been shown that CD169+mac‐
rophages directly modulated the activity of nestin+cells by promoting the expression of HSC
maintenance molecules, including angiopoietin, CXCL12, SCF and VCAM-1. Factors con‐
cerned with these effects are unknown, although some inflammatory molecules have been
implicated [107].
Another key question on the regulation of haematopoiesis is how the BM “knows” the
necessities of different blood cell subsets at any time and responds to the peripheral demand
in each case. Every day there is an enormous production of blood cells and it is necessary to
control precisely the number of each blood cell type in the periphery. Some recent results
suggest an important role of Mo/MØ and neutrophils (Neu) in this control and show the high
plasticity exhibited by the BM stromal components to address these processes. It was reported
that BM responds to Listeria monocytogenes infection inducing migration of inflammatory Mo
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in a process that involves the chemokine receptor CCR2 [110]. CCR2+Mo also migrate from
the BM stroma into peripheral blood through vascular sinusoids in response to low concen‐
trations of LPS, a TLR ligand. In these experimental conditions, there is also a significant
increase in CCL2 production by perivascular CXCL12+nestin+cells [111]. These same authors
showed that conditional deletion of the CCL2 gene under the control of nestin promoter
coursed with an important reduction of circulating inflammatory Ly6Chi Mo. The reduction
was less severe when CCL2 gene was deleted in endothelial cells. These results show that
CCL12 gene up-regulation in nestin+cells, CAR cells and endothelial cells is necessary for
inducing migration from the BM into the blood circulation of inflammatory Mo in response to
low concentrations of LPS [111]. A similar behaviour was detected after L. monocytogenes
infection. In mice infected which had deleted the CCL2 gene from nestin+cells, the bacterial
clearance was significantly low [111]. It is unclear, however, how the reticular cells of BM
stroma govern Mo migration and “perceive” the occurrence of TLR ligands (i.e., LPS) in the
circulation, but it is evident that distinct chemokine-chemokine receptor pairs regulate
trafficking of haematopoietic progenitors or their mature progeny between BM and the
peripheral circulation. Nor is it clear how the migration of a specific cell type affects another
blood cell lineage but stimulation of BM-MSC through TLR4 down-regulates the expression
of Jagged, a Notch ligand, involved in HSC self-renewal [112].
These results support the existence of mutual influences between BM stromal cells and
Mo/MØ but also open interesting concerns about the mechanisms of response of the BM to the
peripheral demands of specific blood cell subsets and the possible existence of different stromal
cells that define different niches in the BM microenvironment or, alternatively, a unique nestin
+cell population capable of adapting its function (i.e., production of different chemokines) in
time for the specific demands of the hematopoietic system (see later). The neutrophil is a blood
cell type with a short life-span that reflects a fine-tuned turnover between elimination and
production, particularly in inflammatory situations. Thus, mice with impaired Neu extrava‐
sation, a process necessary for their efficient clearance, results in an imbalance of G-CSF levels
and enhanced granulopoiesis suggesting that Neu elimination is part of a homeostatic loop
for controlling their level in blood [113]. In this respect, it has been proposed that physiological
clearance of Neu in the BM triggers signals that modulate the hematopoietic niche and promote
cycles of hematopoietic progenitor mobilization [114]. Neu during aging lose CD62L expres‐
sion and increase that of CXCR4, that facilitates their migration into the BM [115]. Although
the loss of CD62Llo does not contribute to BM homing, within BM CD62Llo Neu are preferen‐
tially engulfed by MØ as compared to CD62Lhi Neu. On the other hand, the a priori surprising
release of haematopoietic progenitors from BM to peripheral blood during Neu clearance
could be related to increased levels of G-CSF occurring in that condition [113] that favour HSC
mobilization. It may be hypothesized, therefore, that circulating Neu could function as a sensor
of the organism status.
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7. The other niches of adult bone marrow
Until now we have almost exclusively paid attention to the regulation through the BM niche
of early hematopoietic progenitors, their mechanisms of survival, proliferation and differen‐
tiation. However, BM stroma houses many developing cells belonging to different blood cell
lineages that also need to receive signals from the BM microenvironment for maintenance and
maturation. This raises the question of whether the BM constitutes a unique niche capable of
numerous functions that vary in their timing and physiological demands or if, instead, the so-
called BM niche should be considered as a myriad of different specific “subniches”. In the
following pages we will describe some of these “subniches” and their possible relationships
to the previously described microenvironments that house and maintain early hematopoietic
progenitors.
We have previously emphasized the mutual influences between Mo/MØ and BM stromal cells
and their relevance in regulating hematopoietic activity. Erythroblastic islands that are
“classical” BM niches, consisting of a central MØ surrounded by developing erythroid cells,
and are considered essential for normal erythropoiesis [116] represent other distinct environ‐
ments in the BM not associated with HSCs but with erythroblast maturation. Recent results
suggest a dual role for central MØ contributing to both red blood cell production and clearance
in the steady state but playing a supporting role for erythropoiesis during the erythroid
recovery that follows haemolytic anaemia, acute blood loss, myeloablation and JAK2 induced
polycythemia vera [117, 118]. Thus, during the myeloablative process the depletion of
radioresistant CD169+MØ impaired the recovery of BM and splenic erythroblasts. A similar
condition occurred when antibody blockade of V-CAM was performed suggesting that
adhesion molecule-mediated interactions between erythroblasts and MØ are important in this
process.
Lymphoid cells constitute another important component of the BM. B lymphocytes mature in
the BM whereas other lymphoid cell subsets (i.e., plasmablasts, naïve and memory T-cells)
migrate into the BM at any time of their life cycle [13]. The movement of B lymphocytes
throughout the central and peripheral lymphoid organs is a good model to evaluate the
presumptive occurrence of distinct subniches in the BM. As mentioned above, a pioneer study
[2] proposed that primitive B progenitor cells that occurred close to the endosteum progressed
during the maturation of distinct cell subsets along the BM reticular network toward the central
blood vessels where mature B lymphocytes migrated into the blood circulation. Information
on the niches that developing B cells occupy during this journey throughout BM stroma is
scarce. The existence of IL7hi-and IL7lo-niches has been reported but their precise location in
the BM stroma remains unresolved [119]. On the other hand, pre-BcR signalling necessary for
the maturation of pre-pro B cells induces CXCR4 expression and its interaction with CXCL12-
expressing stromal cells induces downstream activation of the focal adhesion kinase that could
facilitate the movement of pre B cells into the IL7lo niches [120].
In the periphery (i.e., lymph nodes, spleen), naïve B lymphocytes activated by antigens, largely
T-dependent ones, become plasmablasts, after passing through the named germinal centres.
The conversion of activated B lymphocytes in plasmablasts courses with down-regulation of
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both CXCR5 and CCR7 and up-regulation of the S1P1 (sphingosine-1-phosphate) receptor
necessary for the exit of plasmablasts from the peripheral lymphoid organs [121]. Plasmablasts
that leave the peripheral lymphoid organs migrate predominantly to the BM in a process
mediated in part by CXCR4 because sinusoidal endothelial cells of BM express its ligand,
CXCL12 [119]. However, other chemokines, including CXCL9, CXCL10 and CXCL11 are also
involved in the homing to murine BM [122]. In humans, other chemokines, such as CXCL16
and CCL28 are implicated [123]. Once in the BM, plasmablasts need to home to appropriate
niches that guarantee their retention, survival and differentiation to mature plasma cells.
CXCL12, some adhesion molecules principally, VCAM1 constitutively expressed by BM
stromal cells, and extracellular matrix molecules, such as fibronectin and hyaluronic acid [124]
contribute to their retention, but remarkably many arriving plasmablasts fail to establish in
the BM. Possible mere competence between arriving plasmablasts, maturing pre-or pro-B cells
and/or pre-existing long-lived plasma cells by the space or, more specifically, by the CXCL12-
expressing niches could explain these results [125]. Another remarkable finding is that about
50% of the recent immigrant plasmablasts interact with eosinophils (Eos), a smaller number
with MØ and some with megakariocytes [126, 127]. In peripheral lymphoid organs most
plasmablasts contact with MØ. The relevance of these cell types for plasmablast colonization
of the BM was evidenced in Eos deficient ∆dbl GATA-1 mice in which plasmablasts migrate
normally, but only a few are retained and mature to plasma cells. Importantly, the BM stroma
in these mutants is normal indicating that VCAM-1+CXCL12+stromal cells are not sufficient
to retain and presumptively to allow plasmablast differentiation [128, 129].
At this point it is important to remark that in vitro studies have shown IL5, IL6, TNFα, BAFF
(B-cell activating factor), APRIL (a proliferation-inducing ligand) and CXCL12 as well as
fibronectin, CD44 and CD28 as plasma cell survival factors [125]. However, in vivo studies
have particularly pointed out the importance of APRIL. APRIL-deficient mice or mice deficient
in BCMA, the high affinity receptor of APRIL, show a significantly lower number of plasma
cells in the BM than WT mice [130, 131]. In addition, plasmablasts transferred into APRIL-
deficient mice home normally in the BM but the maintenance of long-lived plasma cells is
impaired [129] and blockade of BAFF and APRIL by fusion proteins significantly reduced the
plasma cell numbers in the BM [130]. The relevance of APRIL for the survival of plasmablasts
and plasma cells is also shown because SLE patients contain numerous plasma cells whose
survival is controlled by autocrine expression of APRIL in the self plasma cells [132]. Plasma‐
blasts retained in the BM move from the sinusoids into the stroma where clusters of Eos appear
scattered at random throughout the BM parenchyma. These areas containing stromal cells and
Eos become evident late after secondary immunization and could constitute the survival niche
for mature plasma cells. Remarkably, the number of Eos in BM significantly increases during
secondary immune responses when the production of plasma cells peaks. These are activated
producing increased amount of cytokines, including APRIL and IL6. It, therefore, appears that
a positive feedback governed by the plasma cells activate Eos to induce high levels of plasma
cell survival factors.
These results report a new niche in the BM in which stromal cells need APRIL+Eos to home
and maintain both plasmablasts and plasma cells. Nothing is known about the stromal cells
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associated with Eos, if they are similar to those that support the differentiation of early B
lymphocyte progenitors or, by contrast, represent another phenotypic and functional subniche
within the BM microenvironment.
8. Adipocytes as negative regulators of haematopoiesis
Adipocytes, other cell component of BM stroma, that were regarded as a passive element in
the haematopoietic activity occurring in the BM, in fact appear to be active suppressors of
haematopoiesis [133]. Thus, adipocyte-rich BM contains lower numbers of haematopoietic
progenitors and fat cells impede their expansion preserving the HSC pool in a process partially
mediated through increased expression of neurophilin 1, a semaphorine receptor, involved in
angiogenesis and axon guidance [134]. In addition, in lipoathrophic A-ZIP/F1 mice, deficient
in adipocytes, or after pharmacological inhibition of adipogenesis, BM exhibits massive
osteogenesis and rapid recovery of haematopoiesis [135].
All these data suggest that the BM stromal cells, particularly CAR cells and nestin+cells,
represent a highly plastic cell population capable under different physiological conditions, of
differentiating either to bone cell lineage or adipocytes, or constitute a niche for homing and
maintaining hematopoietic progenitors [136].
9. The haematopoietic niches in the lower vertebrates
When we analyze the characteristics, components and functional relevance of the haemato‐
poietic niches we forget that many vertebrates do not contain a haematopoietic BM but exhibit
highly efficient haematopoiesis raising the question of whether they use other mechanisms for
controlling blood production, or if blood-forming organs in lower vertebrates have well
organized haematopoietic niches equivalent to those described here in mammalian BM. A BM
functionally implicated in haematopoiesis appears for the first time in the most evolved
urodeles of the Pletodontidae family [137]. Earlier in phylogeny, particularly in fish, there are
numerous haematopoietic organs which share a structural and functional resemblance to the
BM of higher vertebrates [7]. Apparently, in these lower vertebrates any organ that contains a
stroma consisting of a reticular network arranged between sinusoidal blood vessels could
home and supports differentiation of blood cell progenitors. Obviously, alterations in the
histological organization of these organs would result in the loss of their haematopoietic
capacities.
The variety of organs involved in haematopoiesis in primitive vertebrates is impressive. In
most elasmobranches, masses of haematopoietic tissue can be found in the oesophageal
(Leydig organ) and gonad walls (Epigonal organs) [138]. The kidney is the main haemato‐
poietic organ in many lower vertebrates, including cyclostomes, chondrostei, holostei, dipnoi,
polypteriformi, teleostei, some urodelans and embryonic anurans. In this case, cell cords
Adult Stem Cell Niches34
containing developing blood cells occur arranged among the renal tubules and enlarged blood
sinusoids.
The brain and cranium are also suitable sites for haematopoiesis. It occurs in the meninx
primitive of some elasmobranches [139] and in the orbit and subcranium of the holocephali,
Chimaera monstrosa [140, 141]. An analogous tissue occurs in the meninges of ganoids [142] and
in the brain of the urodeles Ambystoma [143] and Megalobatrachus japonica [144]. The importance
of niches for determining the haematopoietic capacity of distinct organs is evidenced during
the ontogeny of amphibians and throughout the complex life cycle of lampreys. In amphibians
which do not have haematopoietic BM, the kidney retains the blood-forming function. In
contrast, in the urodeles of the Plethodontidae family which already contain a haematopoietic
BM, the kidney is not capable of producing blood cells [137]. In adult anurans with a functional
BM, the kidney which had formed blood cells during embryonic and foetal life also loses its
hematopoietic capacity [145], although some primitive families (i.e., Pipidae) maintain a
granulopoietic perihepatic cell layer [146]. In larval lampreys, the typhlosole, a fold of the
midgut, and the nephric fold consisting of the larval opistonephros and a little closely-
associated adipose tissue are the main haematopoietic organs. All of these have a histological
organization similar to that of mammalian BM. During metamorphosis, these organs, partic‐
ularly the typhlosole, regress completely because the reticular network that constituted the
haematopoietic niche is substituted by fibroblasts and masses of collagen fibres. After meta‐
morphosis, when the adult opistonephros is organized, the haematopoietic tissue re-appears
there, although the most remarkable adult haematopoietic organ in lampreys is the supraneu‐
ral body. In larvae, this fat column along the central nervous system only contains adipocytes
but just after metamorphosis it begins to home blood cell progenitors in cell cords arranged
among big fat cells resembling the organization of BM of higher vertebrates [147].
10. Concluding remarks
It is evident that in a few years the data on the organization, cell and molecular components
of adult BM have increased exponentially. However, this mass of information has generated
new, important questions that reflect the enormous complexity of the haematopoietic niche
and its physiology. The haematopoietic niche is more complex and heterogeneous than the
current picture we have owing to the limited cell markers and experimental approaches
available. To determine whether this heterogeneity is real, or rather reflects a high plasticity
that permits a specific cell type to change its functionality throughout time depending on
physiological demands is an important matter that needs an urgent answer. Before this global
issue can be resolved we must first address some specific points:
1. An accurate, fine anatomical analysis of the BM is required which permits the precise
location of the different components and the relationships between bone, blood vessels
(arterioles and sinusoids) and reticular cells to be conclusively established.
2. The relationships between CAR cells, nestin+cells and LepR+cells are unclear. Although
they presumably overlap considerably it will be important to define precisely which cell
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type (and its possible subsets) is included in each cell population and what is its function
in the haematopoietic niche.
3. The physiological significance of the homeostatic changes in the biology of haematopoietic
niches also needs clarification and the appearance and maturation of distinct stromal
components of BM during ontogeny, aging and disease must be determined.
4. It is also important to define the genes/signals involved in the maintenance and differen‐
tiation of various haematopoietic progenitor subsets as well as those that specifically
differentiate BM stromal cells to either adipocytes or bone cells.
More importantly, we need to have an integrative model that allows to us to understand the
complex interactions that govern haematopoiesis through the BM microenvironment in
physiological and pathological conditions. Most self-renewing organs are supported by a
myriad of stem cell niche units, distributed throughout the tissue. Moreover, growing evidence
points to high heterogeneity in terms of molecular profiles, division patterns and population
sizes of stem cells and niches within a given tissue [148]. Organs, therefore, face the consider‐
able challenge of regulating not only each individual niche but also critically, the collective
output of all the niches in a given organ. It is, therefore, important to define how multiple,
heterogeneous and spatially dispersed units are coordinated in a tissue,
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